Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
मुख्य लेखक: | Flora, Sanzida Alam |
---|---|
अन्य लेखक: | Azam, Faruque |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
Brac University
2024
|
विषय: | |
ऑनलाइन पहुंच: | http://hdl.handle.net/10361/23693 |
समान संसाधन
-
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
द्वारा: Khan, Muidul Hasan
प्रकाशित: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
द्वारा: Paul, Pulock
प्रकाशित: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
द्वारा: Rahman, Tasnim
प्रकाशित: (2024) -
A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
द्वारा: Sorno, Rubina Haque
प्रकाशित: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
द्वारा: Hoque, Ismoth Ara
प्रकाशित: (2024)